Pluri Inc. Derivative, Excluded Component, Gain (Loss), Recognized in Earnings
Pluri Inc. (PLUR) reported Derivative, Excluded Component, Gain (Loss), Recognized in Earnings of $9.00 thousand for the 3-month period ending 2020-12-31, per its 10-Q filed 2021-02-08.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings · last filed 2021-02-08
- Pluri Inc. derivative, excluded component, gain (loss), recognized in earnings for the quarter ending 2020-12-31 was $9.00K, a 57.14% decline year-over-year.
- Pluri Inc. derivative, excluded component, gain (loss), recognized in earnings for the quarter ending 2020-09-30 was $13.00K, a 84.34% decline year-over-year.
- Pluri Inc. derivative, excluded component, gain (loss), recognized in earnings for the quarter ending 2020-06-30 was -$270.00K, a 1688.24% decline year-over-year.
- Pluri Inc. derivative, excluded component, gain (loss), recognized in earnings for the quarter ending 2020-03-31 was -$132.00K.
- Pluri Inc. derivative, excluded component, gain (loss), recognized in earnings for fiscal 2020 was $13.00K.
- Pluri Inc. derivative, excluded component, gain (loss), recognized in earnings for fiscal 2019 was -$105.00K.
- Pluri Inc. derivative, excluded component, gain (loss), recognized in earnings for fiscal 2018 was -$264.00K, a 154.89% decline from fiscal 2017.
- Pluri Inc. derivative, excluded component, gain (loss), recognized in earnings for fiscal 2017 was $481.00K.
| Period end | Derivative, Excluded Component, Gain (Loss), Recognized in Earnings 3 month | Derivative, Excluded Component, Gain (Loss), Recognized in Earnings 3 month as first filed | Derivative, Excluded Component, Gain (Loss), Recognized in Earnings 6 month | Derivative, Excluded Component, Gain (Loss), Recognized in Earnings 6 month as first filed | Derivative, Excluded Component, Gain (Loss), Recognized in Earnings 9 month | Derivative, Excluded Component, Gain (Loss), Recognized in Earnings 12 month |
|---|---|---|---|---|---|---|
| 2020-12-31 | $9.00K 10-Q · filed 2021-02-08 | -$26.00K 10-Q · filed 2021-02-08 | -$248.00K derived: sum of 3 quarters · filed 2021-02-08 | -$380.00K derived: sum of 4 quarters · filed 2021-02-08 | ||
| 2020-09-30 | $13.00K 10-Q · filed 2020-11-05 | -$257.00K derived: sum of 2 quarters · filed 2020-11-05 | -$389.00K derived: sum of 3 quarters · filed 2020-11-05 | -$368.00K derived: sum of 4 quarters · filed 2021-02-08 | ||
| 2020-06-30 | -$270.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | -$402.00K derived: sum of 2 quarters · filed 2020-09-10 | -$381.00K derived: sum of 3 quarters · filed 2021-02-08 | $13.00K 10-K · filed 2020-09-10 | ||
| 2020-03-31 | -$132.00K 10-Q · filed 2020-05-11 | -$111.00K derived: sum of 2 quarters · filed 2021-02-08 | $283.00K 10-Q · filed 2020-05-11 | -$11.00K derived: sum of 4 quarters · filed 2021-02-08 | ||
| 2019-12-31 | $21.00K 10-Q · filed 2021-02-08 | -$26.00K 10-Q · filed 2020-02-06 | $57.00K 10-Q · filed 2021-02-08 | -$492.00K 10-Q · filed 2020-02-06 | $121.00K derived: sum of 3 quarters · filed 2021-02-08 | $46.00K derived: sum of 4 quarters · filed 2021-02-08 |
| 2019-09-30 | $83.00K 10-Q · filed 2020-11-05 | $100.00K derived: sum of 2 quarters · filed 2020-11-05 | $25.00K derived: sum of 3 quarters · filed 2020-11-05 | $82.00K derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | -$58.00K derived: sum of 2 quarters · filed 2020-09-10 | -$1.00K derived: sum of 3 quarters · filed 2020-09-10 | -$105.00K 10-K · filed 2020-09-10 | ||
| 2019-03-31 | -$75.00K 10-Q · filed 2020-05-11 | -$18.00K derived: sum of 2 quarters · filed 2020-05-11 | -$122.00K 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $57.00K 10-Q · filed 2020-02-06 | -$405.00K 10-Q · filed 2020-02-06 | ||||
| 2018-09-30 | $87.00K 10-Q · filed 2019-11-07 | |||||
| 2018-06-30 | -$264.00K 10-K · filed 2020-09-10 | |||||
| 2017-06-30 | $481.00K 10-K · filed 2019-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |